chr1-28993489-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong
The ENST00000373800.7(EPB41):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
EPB41
ENST00000373800.7 start_lost
ENST00000373800.7 start_lost
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 7.69
Genes affected
EPB41 (HGNC:3377): (erythrocyte membrane protein band 4.1) The protein encoded by this gene, together with spectrin and actin, constitute the red cell membrane cytoskeletal network. This complex plays a critical role in erythrocyte shape and deformability. Mutations in this gene are associated with type 1 elliptocytosis (EL1). Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 20 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in ENST00000373800.7 (EPB41) was described as [Pathogenic] in ClinVar as 16714
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-28993489-A-G is Pathogenic according to our data. Variant chr1-28993489-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 618091.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPB41 | NM_001376013.1 | c.628A>G | p.Met210Val | missense_variant | 3/21 | ENST00000343067.9 | NP_001362942.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPB41 | ENST00000343067.9 | c.628A>G | p.Met210Val | missense_variant | 3/21 | 5 | NM_001376013.1 | ENSP00000345259 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 12, 2019 | PVS1, PM2, PP5 - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 24, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;.;T;T;.;.;.;.;.;.;.;T;.;.;.;.;.;.;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;T;D;D;D;D;D;D;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;.;.;.;.;.;.;L;.;L;.;.;.;.;L;.;.
MutationTaster
Benign
D;D;D;D;D;D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
.;.;N;N;.;.;.;N;.;N;.;N;.;.;.;.;N;.;.
REVEL
Uncertain
Sift
Benign
.;.;T;D;.;.;.;T;.;T;.;T;.;.;.;.;T;.;.
Sift4G
Benign
.;.;T;T;.;.;.;T;.;T;.;T;.;.;.;.;T;.;.
Polyphen
B;.;B;.;.;.;.;P;.;B;.;B;.;.;.;.;P;.;.
Vest4
0.69, 0.76, 0.75, 0.72, 0.68, 0.69
MutPred
0.34
.;.;Loss of catalytic residue at M210 (P = 8e-04);.;.;.;.;.;.;Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);Loss of catalytic residue at M210 (P = 8e-04);
MVP
0.87
MPC
0.74
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at